Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3



Status:Completed
Conditions:Psychiatric, Gastrointestinal
Therapuetic Areas:Gastroenterology, Psychiatry / Psychology
Healthy:No
Age Range:18 - 65
Updated:5/7/2016
Start Date:July 1997
End Date:August 1997

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III

The purpose of this study is to compare the clinical efficacy of the buprenorphine/naloxone
combination tablet to methadone for opioid maintenance treatment.

S/A brief "Summary for the Public"

Inclusion Criteria:

Individuals must be at least 18 years of age, currently opioid dependent and meet FDA
criteria for narcotic maintenance treatment. Co-morbid substance abuse or dependence
disorders may also be present. Individuals must be healthy despite drug dependency.

Exclusion Criteria:

Individuals with evidence of an active Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness,
organic psychiatric disorders), significant medical illness (e.g. liver or cardiovascular
disease) or pregnant female subjects are excluded from study participation.
We found this trial at
1
site
University of Colorado Health Sciences Center
Denver, Colorado 80262
?
mi
from
Denver, CO
Click here to add this to my saved trials